Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(56 sites)
United States
Banner MD Anderson Cancer Center, Gilbert, Arizona Mayo Clinic, Phoenix, Arizona University of Southern California, Los Angeles, California UCLA Ronald Reagan Medical Center, Los Angeles, California Mayo Clinic, Jacksonville, Florida Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, Indiana University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, Maryland Massachusetts General Hospital, Boston, Massachusetts University of Michigan Hospitals, Ann Arbor, Michigan Karmanos Cancer Institute, Detroit, Michigan Mayo Clinic, Rochester, Minnesota Hackensack University Medical Center - John Theurer Cancer Center, Hackensack, New Jersey Roswell Park Comprehensive Cancer Center, Buffalo, New York Weill Cornell Medical College - NY Presbyterian Hospital, New York, New York The Mount Sinai Hospital, New York, New York Duke Cancer Institute, Durham, North Carolina Oklahoma University Health - Stephenson Cancer Center, Oklahoma City, Oklahoma UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania Vanderbilt-Ingram Cancer Center, Nashville, Tennessee Harold C. Simmons Comprehensive Cancer Center - UT Southwestern Medical Center, Dallas, Texas MD Anderson Cancer Center, Houston, Texas Fred Hutchinson Cancer Research Center, Seattle, Washington Belgium
AZ Delta - Campus Rumbeke, Roeselare Canada
Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia McMaster University Juravinski Cancer Centre, Hamilton, Ontario Hopital Maisonneuve-Rosemont, Montreal, Quebec Hopital de l'Enfant-Jesus - Centre Integre en Cancerologie du CHU de Quebec - Universite Laval, Québec, Quebec France
Centre Hospitalier Universitaire de Lille, Lille Centre Hospitalier Universitaire de Nantes, Nantes Hopital Saint Louis, Paris Magendie Hopital Haut-Leveque, Pessac Centre Hospitalier Lyon Sud, Pierre-Bénite Institut Gustave Roussy, Villejuif Germany
Charitè-Campus Benjamin Franklin, Berlin University Medicine Greifswald, Greifswald Medizinische Hochsschule Hannover, Hanover Johannes Gutenberg - University Mainz, Mainz Italy
Institute of Hematology and Medical Oncology "L. and A. Seragnoli", Bologna IRCCS Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori", Meldola UO Ematologia Ospedale di Ravenna, Ravenna Institution Fondazione Policlinico Tor Vergata, Roma Poland
Nasz Lekarz Przychodnie Medyczne, Torun Spain
Hospital Universitari Vall d'Hebron, Barcelona Universitat de Barcelona, Barcelona MD Anderson Cancer Center, Madrid Hospital Universitario HM Sanchinarro, Madrid Hospital Universitario Central de Asturias, Oviedo Hospital Universitario Virgen del Rocio, Seville Hospital Universitari i Politecnic La Fe, Valencia United Kingdom
Cardiff and Vale University, Cardiff Beatson West of Scotland Cancer Centre, Glasgow Barts Health NHS Trust, London St. George's Hospital, London